Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective (Q36391076)

13 August 2017

1 reference

title

Breast cancer, oestrogens and environmental pollutants: a re-evaluation from a mixture perspective (English)

1 reference

13 August 2017

Andreas Kortenkamp

1

1 reference

13 August 2017

1 February 2006

1 reference

International Journal of Andrology

13 August 2017

1 reference

13 August 2017

29

1 reference

13 August 2017

1

1 reference

13 August 2017

193-198

1 reference

Breast cancer incidence and mortality trends in 16 European countries.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Breast cancer risk and the combined effect of environmental estrogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Proportion of breast cancer cases in the United States explained by well-established risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Defining the impact of weakly estrogenic chemicals on the action of steroidal estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Something from "nothing"--eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

Meta-analysis: dietary fat intake, serum estrogen levels, and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2605.2005.00613.X

10.1111/J.1365-2605.2005.00613.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16466540